Sarepta Therapeutics · NASDAQ: SRPT · Biotechnology
Over the past week, Sarepta Therapeutics (SRPT) logged about 11 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 7% bullish but is sharply divided: X runs 22% bullish while News sits at just 0%. Wall Street is more constructive, with 6 of 24 analysts rating SRPT a buy.
There is little buzz around SRPT this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 25% buy share sits next to a crowd that ranges from News at 0% to X at 22%. No other tracker puts the two side by side.
24 analysts have weighed in: a Hold consensus: 6 buy calls against 5 sell, with an average 12-month price target of $22.08.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources only partly agree, so the read is a Sell.
Analysts sit 18 points above the crowd average of 7%, the professionals are more constructive than retail. The split is inside the crowd: X reads 22% bullish while News sits at 0%, a 22-point spread that single-source trackers miss.
Over the 30-day window, Sarepta Therapeutics (SRPT) buzz held subdued around 26.9 while the price drifted up 20.2% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 4.2M shares. Updated Jul 13, 2026. Over the last 7 trading days, SRPT gained 4.1%. Buzz activity in the recent week averaged 31.6 and was relatively stable, swinging between 26.9 and 36.6. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 6 of the 12 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for SRPT and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live SRPT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 13, 2026.
Based on aggregated sentiment from Reddit, X and News sources, Sarepta Therapeutics (SRPT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 7% bullish across 3 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Sarepta Therapeutics (SRPT) is fairly quiet with 1 mentions across 3 tracked subreddits. The tone is 0% bullish with falling 3-day activity momentum, suggesting cooling attention.
Sarepta Therapeutics (SRPT) sentiment is bearish across all 3 tracked sources. X reads 22% bullish, News reads 0% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Social sentiment data shows consistently bearish discussion around Sarepta Therapeutics (SRPT). All 3 tracked sources lean negative, with reddit being the most bearish at 0% bullish. 3-day activity momentum is falling on Reddit and X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 9 mentions (82% of total volume). Reddit contributes 1 mentions and News contributes 1 mentions. Sentiment is bearish across all sources, while news is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. SRPT's sell signal at 93/100 conviction reflects consistently bearish sentiment across multiple platforms. It is a research shortcut, not financial advice.
The SRPT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Sarepta Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry sell signals, pointing to broad bearish pressure rather than an SRPT-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key